Confluent, Inc. (CFLT) insider buying and SEC filings
Confluent, Inc. · CIK 1699838
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Industry (SIC)
- Services-Prepackaged Software
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$2.0M
Planned sales (10b5-1)
$53.2M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Mar 12, 2026 | Planned (10b5-1) | Rohan Sivaram (CFO) sold 29,996 shares at $30.67 ($920K), marked as a 10b5-1 plan trade. Holdings down 5% to 531,971 shares. | SEC filing Filed Mar 13, 2026 |
| Feb 20–24, 2026 | Planned (10b5-1) | Ban Ryan Norris Mac (Chief Revenue Officer) sold 31,273 shares between Feb 20 and Feb 24 at about $30.67 ($959K), marked as a 10b5-1 plan trade. Holdings down 8% to 358,890 shares. | SEC filing Filed Feb 24, 2026 |
| Feb 20, 2026 | Sale | Kong Phan (Chief Accounting Officer) sold 2,277 shares at $30.70 ($70K). Holdings down 1% to 218,228 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 24, 2026 |
| Feb 20, 2026 | Sale | Rohan Sivaram (CFO) sold 21,503 shares at $30.70 ($660K). Holdings down 4% to 561,966 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 24, 2026 |
| Feb 20, 2026 | Planned (10b5-1) | Edward Jay Kreps (CEO and Director) sold 270,207 shares at $30.70 ($8.3M), marked as a 10b5-1 plan trade. Holdings down 47% to 301,660 shares. | SEC filing Filed Feb 24, 2026 |
| Feb 13–18, 2026 | Planned (10b5-1) | Ban Ryan Norris Mac (Chief Revenue Officer) sold 3,768 shares between Feb 13 and Feb 18 at about $30.58 ($115K), marked as a 10b5-1 plan trade. Holdings down 1% to 390,163 shares. | SEC filing Filed Feb 18, 2026 |
| Feb 13, 2026 | Planned (10b5-1) | Neha Narkhede (Director) sold 80,000 shares at $30.59 ($2.4M), marked as a 10b5-1 plan trade. Holdings down 74% to 28,549 shares. | SEC filing Filed Feb 18, 2026 |
| Feb 13, 2026 | Planned (10b5-1) | Michelangelo Volpi (Director) sold 25,000 shares indirectly (by trust) at $30.59 ($765K), marked as a 10b5-1 plan trade. Holdings by trust down 14% to 155,512 shares. | SEC filing Filed Feb 18, 2026 |
| Feb 13, 2026 | Planned (10b5-1) | Eric Vishria (Director) sold 61,905 shares indirectly at $30.57 ($1.9M), marked as a 10b5-1 plan trade. Indirect holdings down 9% to 663,637 shares. | SEC filing Filed Feb 18, 2026 |
| Dec 22–23, 2025 | Sale | Ban Ryan Norris Mac (Chief Revenue Officer) sold 4,271 shares between Dec 22, 2025 and Dec 23, 2025 at $29.96 ($128K). Holdings down 1% to 332,679 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 23, 2025 |
| Dec 22, 2025 | Sale | Kong Phan (Chief Accounting Officer) sold 4,545 shares at $29.96 ($136K). Holdings down 2% to 220,505 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 23, 2025 |
| Dec 12–15, 2025 | Planned (10b5-1) | Edward Jay Kreps (CEO and Director) sold 738,500 shares between Dec 12, 2025 and Dec 15, 2025 at about $30.06 ($22.2M), marked as a 10b5-1 plan trade. Holdings down 69% to 339,367 shares. | SEC filing Filed Dec 16, 2025 |
| Dec 10, 2025 | Planned (10b5-1) | Neha Narkhede (Director) sold 23,100 shares at $30.00 ($693K), marked as a 10b5-1 plan trade. Holdings down 45% to 28,549 shares. | SEC filing Filed Dec 12, 2025 |
| Dec 10, 2025 | Planned (10b5-1) | Lara Caimi (Director) sold 1,074 shares at $30.00 ($32K), marked as a 10b5-1 plan trade. Holdings down 9% to 11,524 shares. | SEC filing Filed Dec 12, 2025 |
| Dec 10, 2025 | Planned (10b5-1) | Alyssa Henry (Director) sold 62,500 shares at $30.00 ($1.9M), marked as a 10b5-1 plan trade. Holdings down 69% to 28,549 shares. | SEC filing Filed Dec 12, 2025 |
| Dec 10, 2025 | Planned (10b5-1) | Eric Vishria (Director) sold 15,476 shares indirectly at $30.00 ($464K), marked as a 10b5-1 plan trade. Indirect holdings down 1% to 1,061,542 shares. | SEC filing Filed Dec 12, 2025 |
| Dec 8, 2025 | Planned (10b5-1) | Ban Ryan Norris Mac (Chief Revenue Officer) sold 44,114 shares at $29.77 ($1.3M), marked as a 10b5-1 plan trade. Holdings down 12% to 336,950 shares. | SEC filing Filed Dec 10, 2025 |
| Dec 8, 2025 | Planned (10b5-1) | Kong Phan (Chief Accounting Officer) sold 3,841 shares at $29.84 ($115K), marked as a 10b5-1 plan trade. Holdings down 2% to 225,050 shares. | SEC filing Filed Dec 10, 2025 |
| Dec 8, 2025 | Planned (10b5-1) | Rohan Sivaram (CFO) sold 3,000 shares at $29.84 ($90K), marked as a 10b5-1 plan trade. Holdings down 1% to 588,738 shares. | SEC filing Filed Dec 10, 2025 |
| Dec 8, 2025 | Planned (10b5-1) | Neha Narkhede (Director) sold 40,000 shares at $29.77 ($1.2M), marked as a 10b5-1 plan trade. Holdings down 58% to 28,549 shares. | SEC filing Filed Dec 10, 2025 |
| Dec 8, 2025 | Planned (10b5-1) | Michelangelo Volpi (Director) sold 50,000 shares directly and indirectly (by trust) at $29.77 ($1.5M), marked as a 10b5-1 plan trade. Direct holdings down 12% to 235,041 shares. | SEC filing Filed Dec 10, 2025 |
| Dec 8, 2025 | Planned (10b5-1) | Eric Vishria (Director) sold 15,476 shares indirectly at $29.84 ($462K), marked as a 10b5-1 plan trade. Indirect holdings down 1% to 1,077,018 shares. | SEC filing Filed Dec 10, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Rohan Sivaram (CFO) sold 8,000 shares at $22.12 ($177K), marked as a 10b5-1 plan trade. Holdings down 1% to 591,738 shares. | SEC filing Filed Dec 3, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Neha Narkhede (Director) sold 30,000 shares at $22.15 ($665K), marked as a 10b5-1 plan trade. Holdings down 51% to 28,549 shares. | SEC filing Filed Dec 3, 2025 |
| Nov 20, 2025 | Sale | Ban Ryan Norris Mac (Chief Revenue Officer) sold 15,062 shares at $22.51 ($339K). Holdings down 4% to 381,064 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 24, 2025 |
| Nov 20, 2025 | Sale | Kong Phan (Chief Accounting Officer) sold 2,640 shares at $22.51 ($59K). Holdings down 1% to 228,891 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 24, 2025 |
| Nov 20, 2025 | Sale | Rohan Sivaram (CFO) sold 25,858 shares at $22.51 ($582K). Holdings down 4% to 599,738 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 24, 2025 |
| Nov 20, 2025 | Planned (10b5-1) | Edward Jay Kreps (CEO and Director) sold 37,707 shares at about $22.20 ($837K), marked as a 10b5-1 plan trade. Holdings down 10% to 339,367 shares. | SEC filing Filed Nov 24, 2025 |
| Nov 13, 2025 | Planned (10b5-1) | Edward Jay Kreps (CEO and Director) sold 232,500 shares at $23.53 ($5.5M), marked as a 10b5-1 plan trade. Holdings down 38% to 377,074 shares. | SEC filing Filed Nov 17, 2025 |
| Nov 3, 2025 | Planned (10b5-1) | Neha Narkhede (Director) sold 30,000 shares at $23.57 ($707K), marked as a 10b5-1 plan trade. Holdings down 51% to 28,549 shares. | SEC filing Filed Nov 5, 2025 |
24 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CFLT in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.